Tostran 2% Gel

Quick links

Choose a section

Quick links to important sections

Advertisements

Tostran 2% Gel

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Tostran 2% Gel

Tostran 2% Gel is a prescription-only medicine that provides androgen replacement therapy (ART) for adult males confirmed to have a deficiency in the endogenous sex hormone Testosterone. The medication’s primary purpose is hormone restoration, working to correct the underlying hormonal imbalance known as male hypogonadism.

Property Description
Active ingredient Testosterone
Form Transdermal Gel (20 mg/g concentration)
Pharmacological class Androgen; Sex hormones and modulators
Common use Testosterone replacement therapy in men with confirmed hypogonadism
Origin Synthetic (chemically identical to natural hormone)

Composition and Form: The Transdermal Gel System

Tostran 2% Gel is supplied as a clear, colorless to slightly yellow topical preparation in a metered-dose pump. The active ingredient is Testosterone at a 2% concentration. This synthetic hormone is suspended in a hydroalcoholic gel base designed for the cutaneous route of administration.

This specific transdermal gel formulation is a key differentiating factor from other forms, allowing the Testosterone to be absorbed directly through the skin into the bloodstream, a process known as percutaneous absorption. This delivery method bypasses the digestive system and facilitates the necessary systemic absorption.


Type and General Therapeutic Purpose

Tostran belongs to the Androgen class, which falls under the broader category of sex hormones and modulators of the genital system. It functions as a single-ingredient product intended solely to replace the deficient natural Testosterone.

The choice of a transdermal gel is used for promoting a stable and sustained systemic delivery of the hormone. This form of delivery helps maintain serum testosterone levels within the normal range, facilitating a smoother, non-invasive approach to achieving hormonal balance in patients with male hypogonadism.

Advertisements

What side effects are possible with Tostran 2% Gel?

Possible Side Effects and Safety Information

This section details the officially documented adverse reactions and safety characteristics for Tostran 2% Gel (Testosterone), based strictly on regulatory prescribing information from governmental sources such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Officially Documented Adverse Reactions

The most frequently reported effects are classified by the EMA regulatory framework:

Frequency Classification Examples of Adverse Reactions (by System Organ Class)
Very Common (ge 1/10) Skin and Subcutaneous Disorders: Application site reactions (e.g., pruritus, rash, erythema)
Common (ge 1/100 to <1/10) Reproductive System: Gynaecomastia, Increased PSA. Blood: Increased Haemoglobin/Haematocrit. Nervous System: Headache. Vascular: Hypertension. Skin: Acne, Alopecia.

Serious Safety Constraints

The official labeling includes cautions regarding potentially serious risks and safety limitations:

  • Secondary Exposure Risk: The transdermal gel poses a risk of unintentional transfer of testosterone to women and children through skin contact, which can result in signs of virilisation.
  • Prostate and Cardiovascular Risks: Testosterone may accelerate the growth of existing subclinical prostatic cancer. Caution is required in patients with pre-existing severe cardiac, renal, or hepatic insufficiency, as treatment may lead to severe oedema and potential congestive cardiac failure.
  • Thromboembolism: Post-marketing reports document Venous Thromboembolism (VTE), including Deep Vein Thrombosis and Pulmonary Embolism.

Population-Specific Safety Notes

Tostran is not indicated for the pediatric population (under 18 years). Geriatric patients (ge 65 years) require specific monitoring of the prostate and breast due to limited experience and potential risks. Regular monitoring of Prostate Specific Antigen (PSA) and blood cell counts (Haematocrit, Haemoglobin) is required across all user groups.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a specific procedure for managing accidental or intentional over-exposure to Tostran 2% Gel. No detailed clinical presentations or symptom clusters related to an acute overdose event are defined in official regulatory documents.

Overdose Management

Condition Required Action (Official Documentation)
Accidental Over-exposure Wash the application site immediately with soap and water.
Suspected Overdose Discontinue treatment if advised by the treating physician.

When to Contact a Doctor for Symptoms

Symptoms that may indicate a dose of Tostran 2% Gel is too high require prompt contact with your prescribing doctor for a dose adjustment. These symptoms include evidence of excessive androgen exposure or fluid retention:

  • Cardiovascular/Fluid Status: Feeling nauseous, vomiting, noticing changes in skin colour, or developing swollen ankle joints.
  • Neurological/Mood: Feeling irritable or nervous, or noting weight gain.
  • Sexual Health: Having frequently-occurring or persistent erections.
  • Respiratory: Noticing any changes in breathing patterns, including during sleep (potential sleep apnea).

If any of these signs occur, they suggest that the body's testosterone levels are higher than appropriate, necessitating medical review and potential dose adjustment, rather than a self-managed action.

Advertisements

Therapeutic Uses of Tostran 2% Gel

What Tostran 2% Gel Treats: Main Uses and Benefits

Tostran 2% Gel is generally used for Androgen Replacement Therapy (ART) to address the systemic clinical manifestations of confirmed male hypogonadism (testosterone deficiency) in adult males. The core therapeutic purpose is hormone restoration, aimed at supporting the body in achieving or maintaining appropriate testosterone levels. The therapy is relevant in managing health problems associated with this lack of hormone and is applied in clinical settings for confirmed deficiency.

Supporting Sexual Health and Emotional Stability

This application is relevant in clinical settings that involve symptoms that interfere with daily functioning. Tostran is commonly used to help with symptom relief across domains involving reduced sexual desire, erectile dysfunction, and associated mood disturbances. The treatment supports managing symptom clusters linked to emotional well-being and persistent irritability. This provides support that helps ease the overall symptom burden and may help support general well-being during symptomatic phases.

“The aim of this therapy is generally to assist with managing symptoms associated with a prolonged hormonal deficit and help improve general comfort.”

Restoring Physical Vigor and Musculoskeletal Strength

Tostran is commonly used across conditions presenting with symptoms related to systemic imbalance that create noticeable physiological strain. It helps address symptoms like persistent fatigue, decreased physical endurance, and symptoms related to decreased muscle mass and strength. Furthermore, the replacement therapy is considered relevant for supporting bone health and contributing to improved day-to-day comfort.

Quick Fact Relief for Symptom
Energy Support Helps with Fatigue and Low Energy
Physical Vigor Supports Muscle Strength and Endurance
Emotional Health Assists with Mood Swings and Irritability
Advertisements

Eligibility and Restrictions for Use

Eligibility for Tostran 2% Gel

Official regulatory documentation limits the use of Tostran 2% Gel exclusively to adult males who have a documented, confirmed deficiency of endogenous testosterone (male hypogonadism).

Populations Who Must Not Use the Medicine (Contraindications)

Use is contraindicated and absolutely prohibited for women, as well as for any male patient with known or suspected carcinoma of the prostate or carcinoma of the breast. The medicine must also not be used if a patient has a known hypersensitivity to the active substance or excipients, or if severe polycythaemia (haematocrit ge 0.54) is present. Furthermore, the medicine is not indicated for the paediatric population and has not been clinically evaluated in males under 18 years of age.

Populations Requiring Conditional Use

Use is conditionally restricted and requires extreme caution in men with severe conditions such as cardiac, renal, or hepatic insufficiency, or ischaemic heart disease, due to the risk of fluid retention complications. Caution is also necessary for patients with a history of thrombophilia, hypertension, epilepsy, migraine, or untreated severe obstructive sleep apnoea. Clinical experience is noted as limited for men older than 65 years.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Tostran 2% Gel is based on documented pharmacodynamic and exposure-altering effects, as established in official government regulatory documents. These effects mandate monitoring and potential dose adjustments for several specific classes of medicinal products.

Oral Anticoagulants

Co-administration with oral anticoagulants, such as Warfarin, may lead to documented changes in anticoagulant activity. This potential for altered drug exposure requires strict clinical surveillance and more frequent monitoring of coagulation parameters, specifically the International Normalized Ratio (INR) and prothrombin time, throughout the period of combined therapy.

Antidiabetic Agents

Androgens may influence glucose metabolism, leading to a documented decrease in blood glucose levels. This pharmacodynamic potentiation means that patients stabilized on antidiabetic agents, including Insulin, may find a reduction in the required dose of their diabetes medication is necessary. Blood glucose levels must be monitored closely to manage this documented interaction.

Corticosteroids and ACTH

The concurrent use of Tostran with Corticosteroids or Adrenocorticotrophic Hormone (ACTH) may result in a documented increased risk of fluid retention (oedema). This additive pharmacodynamic risk is a specific caution highlighted in the official prescribing information. This risk is noted as requiring particular caution and careful monitoring for patients with pre-existing severe cardiac, renal, or hepatic disease.

Advertisements

Mechanism of Action

Tostran 2% Gel delivers testosterone, an endogenous steroid hormone, across the stratum corneum and into the systemic circulation. Following absorption, testosterone and its biologically active metabolite, dihydrotestosterone (DHT), circulate bound primarily to sex hormone-binding globulin (SHBG) and albumin. The unbound, or free, fraction is the active component that enters target cells via passive diffusion across the plasma membrane.

Inside the cell, free testosterone or DHT binds to the Androgen Receptor (AR), a ligand-activated transcription factor located in the cytoplasm. Ligand binding induces a conformational change in the AR, causing it to dissociate from heat shock proteins (HSPs) and subsequently translocate into the nucleus. This agonist interaction with the nuclear AR leads to binding of the hormone-receptor complex to specific DNA sequences known as Androgen Response Elements (AREs) in the promoter regions of target genes. This binding event modulates the recruitment of co-activator or co-repressor proteins, resulting in the transcriptional regulation of numerous genes. The downstream cascades include modulated gene expression controlling protein synthesis and cellular functions in responsive tissues, leading to systemic physiological modulation of nitrogen balance and anabolic processes.

Advertisements

Dosage and Administration Information

How to Use Tostran 2% Gel

This section outlines the official administration guidelines for Tostran 2% Gel (testosterone).

Administration Scope

Category Instruction
Route of Administration Cutaneous (transdermal) application to the skin.
Dosing Schedule The starting dose is 3 g of gel (60 mg testosterone) applied once daily. The dose is adjusted by a physician based on clinical response and pre-dose morning serum testosterone levels. The maximum allowed dose is 4 g of gel (80 mg testosterone) daily.
Frequency Once daily, preferably at approximately the same time each day (e.g., in the morning).
Age/Sex Restriction Not for use in children or adolescents under 18 years old. Not approved for use in women.

Procedural Steps

Preparation and Application

  1. Pump Priming: Before the very first use, the multi-dose pump must be primed by fully depressing and releasing the actuator seven times (discarding the dispensed gel safely). This step is only necessary once.
  2. Measurement: Depress the pump canister the required number of times to dispense the prescribed dose (the 3 g starting dose requires 6 actuations).
  3. Application Site: Apply the gel to clean, dry, intact skin on the abdomen or the inner thighs. Application sites must be rotated daily. Do not apply to the genitals.
  4. Technique and Drying: Spread the gel as a thin layer and allow it to dry completely for a few minutes before dressing. Thorough rubbing is not necessary.

Post-Application Care

  1. Hygiene: Wash hands thoroughly with soap and water immediately after application.
  2. Transfer Prevention: The application site must be covered with clothing (e.g., a T-shirt) once the gel is dry to minimize the risk of transfer. Wait at least two to three hours after application before showering or bathing. If close skin-to-skin contact is anticipated, the application site must be washed with soap and water beforehand.
Advertisements

Recent Clinical Evidence

Tostran 2% Gel: Recent Clinical Evidence

Clinical research on Tostran 2% gel has primarily focused on its use as Testosterone Replacement Therapy (TRT) for male hypogonadism, defined by both clinical symptoms and low serum testosterone levels. The gel formulation is designed to deliver testosterone through the skin, aiming to restore levels to a mid-normal physiological range.


Efficacy and Pharmacokinetics

Studies in hypogonadal men have evaluated the gel’s ability to normalize serum testosterone levels. A key Phase III trial reported a responder rate of approximately 84% to 86%, with responders defined as participants who achieved an average 24-hour total testosterone concentration within the normal range (e.g., 10.4–36.4 nmol/L) after 90 days of treatment.

The pharmacokinetic profile observed in trials showed that serum testosterone levels typically reached a steady-state within the first 24 hours of application, mimicking a natural diurnal rhythm to some extent. The effects on patient-reported outcomes were also assessed, with studies noting significant reported improvements in sexual function, mood, and overall health-related quality of life after several months of treatment.


Safety and Tolerability

The gel's safety profile has been examined in trials lasting up to nine months. Common adverse events reported across studies included application site reactions (such as irritation, erythema, or rash) and headache.

Monitoring of laboratory parameters showed that an increase in haematocrit and prostate-specific antigen (PSA) were also reported, consistent with the known effects of testosterone therapy. While higher maximum testosterone concentrations were occasionally observed, these did not exhibit a distinct impact on safety parameters in the studies reviewed. The risk of accidental transfer of testosterone to others remains a notable consideration associated with all topical testosterone products.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tostran 2% Gel (FAQ)


Q: Is Tostran 2% Gel designed for treating all types of low testosterone conditions?

Official documents state that Tostran 2% Gel is indicated only for Testosterone Replacement Therapy (TRT) in adult men who have confirmed hypogonadism. This means the deficiency must be documented by both clinical symptoms and low serum testosterone levels. The regulatory information does not support its use for non-specific or undefined symptoms.


Q: How does the 2% concentration of the gel compare to other commonly available topical testosterone products?

The concentration of the gel is only one factor; different topical testosterone products may have varying doses, application instructions, and absorption characteristics. Regulatory documents do not provide direct comparisons or suggest superiority between different products. Ultimate decisions regarding the specific type and strength of TRT are based on individual clinical evaluation.


Q: Is Tostran 2% Gel classified as a controlled substance in major regulatory regions?

Yes, in the United States, the active ingredient testosterone is classified by the Drug Enforcement Administration (DEA) as a Schedule III controlled substance. This regulatory classification signifies that the drug has a medical use but also carries a potential for misuse or dependence.


Q: What is the general difference between Tostran and other common forms of testosterone replacement therapy (TRT)?

Tostran is a transdermal gel applied to the skin, designed to deliver testosterone into the bloodstream in a sustained manner. This delivery method is different from other common forms of testosterone replacement therapy, such as intramuscular injections or transdermal patches. The choice of delivery method, such as a gel, is typically guided by the individual's needs and overall clinical profile.


Q: How long does it typically take for users to notice the intended effects of Tostran?

Studies indicate that the levels of testosterone in the blood typically reach a steady-state within 24 hours of starting the gel. However, the regulatory documents indicate that improvement in clinical symptoms, such as mood and sexual function, may take several months of ongoing treatment.


Q: Is it normal to not feel any different in the first few weeks of using the gel?

Clinical trial data suggests that feeling no difference in the first few weeks is consistent with the product’s expected absorption profile. While the blood hormone levels stabilize quickly, the full therapeutic benefit leading to significant improvements in symptoms has been observed after several months of treatment.


Q: If the gel's effectiveness seems to diminish over a period of time, what does that usually indicate?

If efficacy appears to diminish, the regulatory documents specify that the clinical response and serum testosterone levels must be monitored for potential adjustment or investigation. This monitoring assesses factors that could relate to absorption, adherence, or the need for a dose adjustment.


Q: How long is Tostran 2% Gel typically prescribed for by healthcare providers?

Tostran is a replacement therapy intended to correct a confirmed, chronic hormonal deficiency. Official regulatory information does not specify a standard duration; the length of treatment is individualized and based on the patient's specific diagnosis and clinical response.


Q: Can using Tostran 2% Gel lead to changes in emotional state or anxiety levels?

Clinical studies reported improvements in mood as an outcome of therapy. However, the official patient information notes that irritability, nervousness, or weight gain may be signs of a dose that is too high, and the prescribing physician should be informed.


Q: Why are certain body areas, such as the genitals, forbidden for gel application?

The official product information specifies that application to the genital areas is forbidden. This is because the hydroalcoholic gel base contains a high level of alcohol, which may cause significant local irritation to the skin in these sensitive areas.


Q: How long after application is it considered safe to have skin-to-skin contact with another adult?

To minimize the risk of accidental transfer, the manufacturer states that the application site must be covered with clothing once the gel is dry. If close skin-to-skin contact is anticipated within a few hours of application, the regulatory text advises that the application site is required to be washed with soap and water beforehand.


Q: If an application is missed, what is the general guidance on managing the next dose?

Official product labeling provides specific guidance on the steps to take if a dose is missed. This guidance includes instructions on when to skip a dose and a strict warning against doubling the dose, emphasizing the importance of following the prescribed schedule.


Q: What types of over-the-counter or herbal supplements might potentially interact with Tostran 2% Gel?

The regulatory documents primarily list prescription drug interactions such as oral anticoagulants, antidiabetic agents, and corticosteroids. Official warnings stress the importance of disclosing all other concurrent medications and supplements, as androgens may interact with a wider range of products not specifically listed in the interaction warnings.


Q: Can the use of this medication affect a user's fertility?

Official product information notes that testosterone treatment may potentially decrease the number of sperm (male reproductive cells) produced, especially if used at high doses. The product is also not indicated for the treatment of male sterility.

Advertisements

How should Tostran 2% Gel be stored and disposed of?

Storage and Disposal of Tostran 2% Gel

Tostran 2% Gel must be stored at a temperature not exceeding 25°C and must be protected from extreme cold; the product should not be refrigerated or frozen. The medicine has a total shelf-life of 2 years, but must be used or discarded within 60 days after the canister is first opened.

Storage and Handling

Condition Requirement
Temperature Do not store above 25°C. Do not refrigerate or freeze.
Flammability Flammable until dry; avoid fire, flames, or smoking during application.
Container Rule Keep the metered-dose canister in an upright position after opening.
Child Safety Keep out of the sight and reach of children.

Disposal

Unused or expired product must be disposed of in accordance with local requirements. The gel from the initial six priming depressions of the pump must also be safely discarded.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tostran 2% Gel found in:

A-Z Index: